EMERYVILLE, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that Ron Najafi, Ph.D., Chairman and CEO, will present a corporate and clinical update at the BIO CEO & Investor Conference, held February 10-11, 2014 in New York City. Dr. Najafi along with Tom Paulson, Chief Financial Officer, and David Stroman, Ph.D., Senior Vice President, Ophthalmology, from NovaBay, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
Help employers find you! Check out all the jobs and post your resume.
